Efficacy of the digital health application ORIKO(R) for attention-deficit/hyperactivity disorder (ADHD) in adults: Protocol of a randomized controlled trial

Attention-deficit/hyperactivity disorder (ADHD) often continues into adulthood and affects several million adults in Germany. Many do not receive timely, evidence-based treatment because of long waiting times and limited access to care. Digital health applications offer a low-threshold option to provide guideline-based support. A pilot study of the present app-based program showed encouraging improvements in quality of life and reductions in ADHD symptom severity. This randomized controlled…

via https://pubmed.ncbi.nlm.nih.gov/41884663/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1L37KAMf2b_g4WEK3LmdFuKZu9pO3cN7u4ZmO9PPCPeBLMIw1q&fc=None&ff=20260402010904&v=2.19.0.post6+133c1fe